ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Deceased Donor ABO-Incompatible Kidney Transplantation Has the Potential to Reduce Blood Group Disparity.

M. Manook,1 L. Bradbury,2 D. Osei-Bordom,1 B. Sandhu,1 T. Maggs,1 O. Shaw,1 N. Kessaris,1 S. Shah,3 A. Dorling, N. Mamode.1

1Guy's & St Thomas&apos
Hospital, London, United Kingdom
2NHS Blood & Transplant, Bristol, United Kingdom
3King's College Hospital, London, United Kingdom.

Meeting: 2016 American Transplant Congress

Abstract number: C199

Keywords: Donation, Kidney transplantation, Prediction models

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Kidney Transplantation: AKI/Preservation/DCD

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Acquired Down-Regulation of B Cell Function Induced by Donor Blood Group Antigens After ABO-Incompatible Kidney Transplantation.
  • Tolerance to Graft A-Antigens Following ABO-Incompatible Heart Transplantation (HTx) in a Blood Group A-Transgenic Mouse Model

Introduction: Patients with blood group O or B wait significantly longer for a kidney transplant than other groups. Blood group incompatible transplantation is widely accepted and in some centres, tailored desensitisation treatment is based on baseline anti-A or anti-B antibody titre. We studied the distribution of ABO-antibody titres, and have modelled the effect of altering UK Kidney allocation scheme (NKAS) to allow for patients with low titres to receive a deceased donor ABOi.

Methods: A prospective study of 237 adult patients on the waiting list for a transplant in 2 UK transplant centres. ABO-antibody measurements (anti-A and anti-B) were measured in a single laboratory. Based on the proportions of 'Low' (<1:16) anti-A or anti-B antibodies, 3 simulations were performed. Firstly, a baseline simulation (BASELINE) under current NKAS rules; secondly Simulation 1 (SIM1) permits ABO-I for adults with 'low' titres and Simulation 2 (SIM2) was SIM1 but restricted blood group B to A allocations to those with 000 HLA mismatches.

Results: Of the 237 patients, amongst blood group O 3% had 'Low' anti-A titres and 16% had 'low' anti-B; in blood group B 68% had 'low' anti-A; 75% of Blood group A had 'low' titres. Overall there was little difference in estimated numbers of patients transplanted. More blood group B recipients were transplanted in both simulations (p = 0.037 & 0.015). Median waiting time was reduced for blood group B recipients (BASELINE 2017 days; SIM1 1909 days; SIM2 1778 days, p=0.12) but increased for AB (SIM1 1570 days, SIM2 1584 days; BASELINE 1110 days p=0.01). There was a non-significant increase in the number of 000 HLA-mismatch allocations in both simulations compared to BASELINE (p = 0.19). In SIM1 59% of the Blood group B transplants were estimated to be ABOi, while SIM2 reduced this to 52%.

Discussion: Changing allocation in the UK to allow deceased donor ABOi would not change the number of transplants performed, but would redistribute allocation more fairly amongst blood groups, altering waiting times for accordingly. An unforeseen effect of allocation change increased the number of 000 mismatched transplants. Further work modelling the effect of applying these rules to predicted long-waiting recipients is planned.

CITATION INFORMATION: Manook M, Bradbury L, Osei-Bordom D, Sandhu B, Maggs T, Shaw O, Kessaris N, Shah S, Dorling A, Mamode N. Deceased Donor ABO-Incompatible Kidney Transplantation Has the Potential to Reduce Blood Group Disparity. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Manook M, Bradbury L, Osei-Bordom D, Sandhu B, Maggs T, Shaw O, Kessaris N, Shah S, Dorling A, Mamode N. Deceased Donor ABO-Incompatible Kidney Transplantation Has the Potential to Reduce Blood Group Disparity. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/deceased-donor-abo-incompatible-kidney-transplantation-has-the-potential-to-reduce-blood-group-disparity/. Accessed March 4, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.